机器人辅助胸腔镜肺段切除术在早期非小细胞肺癌治疗中的短期临床效果OA
Short-term clinical outcomes of robot-assisted thoracoscopic segmentectomy for early-stage non-small cell lung cancer
目的:探讨机器人辅助胸腔镜肺段切除术与电视胸腔镜肺段切除术在早期非小细胞肺癌(NSCLC)治疗中的短期临床效果差异,评估机器人辅助胸腔镜肺段切除术的安全性、可行性及微创优势.方法:回顾性分析2022年1月—2024年12月于空军军医大学唐都医院行肺段切除术的110 例早期 NSCLC 患者(肿瘤直径≤2 cm,临床ⅠA 期),按手术方式分为观察组(n=55,行机器人辅助胸腔镜肺段切除术)和对照组(n=55,行电视胸腔镜肺段切除术).比较两组围手术期指标、短期肺功能、炎症因子水平及并发症发生率.结果:与对照组相比,观察组手术时间显著延长,但术中出血量更少,术后首次下床时间更早,术后胸管留置时间及住院时间更短(P<0.05).术后 1 个月及 3 个月,观察组 FEV1、FVC、MVV 水平均高于对照组,炎症因子(CRP、IL-6、IL-8)升高幅度小于对照组,总并发症发生率显著低于对照组(P<0.05).结论:机器人辅助胸腔镜肺段切除术治疗早期 NSCLC 虽手术时间较长,但可减少术中出血、加速术后恢复、保护肺功能、减轻炎症反应并降低并发症风险,是一种安全可行的微创术式,为早期NSCLC手术方式选择提供了循证依据.
Objective:To investigate the differences in short-term clinical outcomes between robot-assisted thoracoscopic segmentectomy and video-assisted thoracoscopic segmentectomy in the treatment of early-stage non-small cell lung cancer(NSCLC),and to evaluate the safety,feasibility,and minimally invasive advantages of robot-assisted thoracoscopic segmentectomy.Methods:A retrospective analysis was conducted on 110 patients with early-stage NSCLC(tumor diameter≤2 cm,clinical stage IA)who underwent segmentectomy at Tangdu Hospital from January 2022 to December 2024.The patients were divided into the observation group(n=55,receiving robot-assisted thoracoscopic segmentectomy)and the control group(n=55,receiving video-assisted thoracoscopic segmentectomy)according to the surgical approach.Perioperative indicators,short-term pulmonary function,inflammatory cytokine levels,and complication rates were compared between the two groups.Results:Compared with the control group,the observation group had a significantly longer operative time,but less intraoperative blood loss,earlier time to first ambulation,and shorter postoperative chest tube duration and length of hospital stay.At 1 and 3 months after surgery,the levels of FEV1,FVC,and MVV in the observation group were higher than those in the control group(P<0.05),the increases in inflammatory cytokines(CRP,IL-6,and IL-8)were smaller than those in the control group,and the overall complication rate was significantly lower than that in the control group(P<0.05).Conclusion:Although robot-assisted thoracoscopic segmentectomy for early-stage NSCLC requires a longer operative time,it can reduce intraoperative bleeding,accelerate postoperative recovery,preserve pulmonary function,alleviate the inflammatory response,and lower the risk of complications.It is a safe and feasible minimally invasive surgical approach,providing evidence-based support for the selection of surgical methods for early-stage NSCLC.
王俊英;段鸿涛;鲍培龙;苏庆;孙雅珺
空军军医大学唐都医院 麻醉手术科 陕西 西安 710038空军军医大学唐都医院 胸腔外科 陕西 西安 710038空军军医大学唐都医院 胸腔外科 陕西 西安 710038空军军医大学唐都医院 麻醉手术科 陕西 西安 710038空军军医大学唐都医院 麻醉手术科 陕西 西安 710038
医药卫生
机器人辅助手术胸腔镜手术肺段切除术早期非小细胞肺癌短期临床效果
Robot-assisted SurgeryThoracoscopic SurgerySegmentectomyEarly-stage Non-small Cell Lung CancerShort-term Clinical Outcomes
《机器人外科学杂志(中英文)》 2026 (9)
1529-1534,6
国家自然科学基金(8200101858) National Natural Science Foundation of China(8200101858)
评论